Is Sudarshan Pharma Industries a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Sudarshan Pharma Industries Ltd is a average quality company .

Is Sudarshan Pharma Industries undervalued or overvalued?

The key valuation ratios of Sudarshan Pharma Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Sudarshan Pharma Industries share price return in the past 10 years?

Data is not available for this company

Is Sudarshan Pharma Industries a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sudarshan Pharma Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Sudarshan Pharma Industries?

The latest standalone P/E ratio of Sudarshan Pharma Industries as of 17-Jun-2025 is 44.56.

What is the P/B ratio of Sudarshan Pharma Industries?

The latest standalone P/B ratio of Sudarshan Pharma Industries as of 17-Jun-2025 is 5.55.

What is the 52-week high and low of Sudarshan Pharma Industries?

The 52-week high of Sudarshan Pharma Industries is Rs. 53.50 and the 52-week low is Rs. 7.35.

Sudarshan Pharma Industries Ltd - Stock Valuation and Financial Performance

Name: Sudarshan Pharma Industries
Brand: Sudarshan Pharma Industries

BSE: 543828 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Sudarshan Pharma Ind Share Price

₹28.82 -0.58 -1.97%
as on 17-Jun'25 16:59

10 Year X-Ray of Sudarshan Pharma Ind:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	16%	12.2%	16%	19.5%	12%	14.6%	18.7%	15.3%	13.7%	-
Value Creation Index ⓘ	0.1	-0.1	0.1	0.4	-0.1	0.1	0.3	0.1	0.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	37.9	55.4	88.2	139	148	193	357	461	466	503
Sales YoY Gr.	-	46.1%	59.2%	57.8%	6.4%	30.7%	84.7%	29.2%	0.9%	-
Adj EPS ⓘ	0.3	0	0.1	0.3	0.1	0.3	0.6	0.3	0.5	0.7
YoY Gr.	-	-88.2%	125%	177.8%	-44%	92.9%	103.7%	-45.5%	56.7%	-
BVPS (₹) ⓘ	0.6	0.9	1.1	2	2.1	2.4	3.1	4.2	4.6	5.3
Adj Net Profit ⓘ	0.1	0.2	0.7	2.3	1.3	2.6	5.3	7.2	11.2	16
Cash Flow from Ops. ⓘ	1.8	-1.6	0	-1	0.5	2.7	-3.7	-28.8	8	-
Debt/CF from Ops. ⓘ	1.2	-3.6	-1286.2	-14.3	40.4	11.1	-8.3	-1.2	13.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	27.3%	34%	0.9%
Adj EPS ⓘ	NA	13.5%	20.3%	56.7%
BVPSⓘ	NA	18.8%	25.3%	10.5%
Share Price	-	-	-	295.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	56.1	9.3	12.6	17.2	6.9	12.3	20.3	11	10.6	13.3
Op. Profit Mgn % ⓘ	0.9	1.1	0.8	3.1	3.3	3.7	3.1	3.2	4.9	NAN
Net Profit Mgn % ⓘ	0.2	0.3	0.8	1.7	0.9	1.3	1.5	1.6	2.4	3.2
Debt to Equity ⓘ	12.9	1.8	1.2	0.8	1.1	1.3	1	0.3	1	-
Working Cap Days ⓘ	0	88	102	96	116	135	113	126	170	0
Cash Conv. Cycle ⓘ	0	28	40	42	61	65	46	45	82	0

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 34.03%

Net Profit is growing at healthy rate in last 3 years 20.29%

Debt to equity has declined versus last 3 years average to 0.96

Return on Equity has declined versus last 3 years average to 13.30%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Sudarshan Pharma Industries Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.7	0.7
TTM Sales (₹ Cr.)	503	505
BVPS (₹.) ⓘ	5.3	5.3
Reserves (₹ Cr.) ⓘ	103	104
P/BV ⓘ	5.55	5.54
PE ⓘ	44.56	44.35

From the Market
52 Week Low / High (₹)	7.35 / 53.50
All Time Low / High (₹)	5.18 / 53.50
Market Cap (₹ Cr.)	708
Equity (₹ Cr.)	24.1
Face Value (₹)	1
Industry PE ⓘ	41.7

Management X-Ray of Sudarshan Pharma Ind:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Sudarshan Pharma Ind

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Sudarshan Pharma Ind

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	38	55	88	139	148	193	357	461	466
Operating Expenses ⓘ	38	55	87	135	143	186	346	447	443
Manufacturing Costs	0	0	0	1	1	2	3	5	4
Material Costs	36	53	83	129	137	178	335	431	425
Employee Cost	0	1	2	2	2	1	2	2	3
Other Costs ⓘ	1	1	2	2	4	6	7	9	12
Operating Profit ⓘ	0	1	1	4	5	7	11	15	23
Operating Profit Margin (%)	0.9%	1.1%	0.8%	3.1%	3.2%	3.7%	3.1%	3.2%	4.9%
Other Income ⓘ	0	0	2	1	0	0	0	1	3
Interest ⓘ	0	0	1	2	3	3	3	5	9
Depreciation ⓘ	0	0	0	0	0	1	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0	1	3	2	4	7	9	15
Tax ⓘ	0	0	0	1	0	1	2	2	4
Profit After Tax	0	0	1	2	1	3	5	7	11
PAT Margin (%)	0.2%	0.3%	0.8%	1.7%	0.9%	1.4%	1.5%	1.5%	2.4%
Adjusted EPS (₹)	0.3	0.0	0.1	0.3	0.1	0.3	0.5	0.3	0.5
Dividend Payout Ratio (%)	0%	96%	0%	0%	0%	0%	0%	10%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	0	3	9	19	20	23	30	101	112
Share Capital ⓘ	0	2	5	10	10	10	10	24	24
Reserves ⓘ	0	1	4	9	10	13	20	77	88
Minority Interest	0	0	0	0	0	0	0	0	0
Debt	2	6	10	14	21	30	29	31	103
Long Term Debt	1	2	3	4	7	8	5	13	10
Short Term Debt	1	3	8	10	14	21	24	18	93
Trade Payables	6	11	12	16	15	44	74	92	57
Others Liabilities ⓘ	0	0	1	1	2	3	5	8	14
Total Liabilities ⓘ	8	20	31	50	58	99	138	232	285
Fixed Assets
Gross Block	0	0	0	2	6	8	8	22	24
Accumulated Depreciation	0	0	0	0	1	1	2	3	4
Net Fixed Assetsⓘ	0	0	0	2	6	6	6	20	21
CWIP ⓘ	0	0	0	2	0	0	1	0	2
Investmentsⓘ	0	0	0	0	0	0	0	12	17
Inventories	1	3	7	10	17	24	47	75	84
Trade Receivables	7	14	17	26	27	60	73	82	123
Cash Equivalents	0	1	0	4	1	1	0	12	0
Others Assetsⓘ	0	2	7	7	7	7	10	32	38
Total Assets ⓘ	8	20	31	50	58	99	138	232	285

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	2	-2	0	-1	1	3	-4	-29	8
PBT ⓘ	0	0	1	3	2	4	7	9	15
Adjustment ⓘ	0	0	1	2	3	4	4	6	9
Changes in Working Capital ⓘ	1	-2	-2	-5	-4	-4	-13	-42	-14
Tax Paid ⓘ	0	0	0	-1	0	-1	-2	-2	-2
Cash Flow From Investing Activity ⓘ	0	0	0	-3	-3	-1	-2	-26	-7
Capex	0	0	0	-3	-4	-1	-1	-14	-2
Net Investments	0	0	0	0	0	0	0	-12	-4
Others ⓘ	0	0	0	0	2	0	0	1	-1
Cash Flow From Financing Activityⓘ	-2	2	-1	8	0	-1	4	66	-12
Net Proceeds from Shares ⓘ	0	3	5	8	0	0	2	64	0
Net Proceeds from Borrowing ⓘ	-1	0	-4	2	3	1	6	8	-2
Interest Paid ⓘ	0	0	-1	-2	-3	-3	-3	-5	-9
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	-1
Others ⓘ	0	0	0	0	0	0	0	-1	0
Net Cash Flow ⓘ	0	0	-1	3	-2	0	-1	11	-12

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	N/A	9.26	12.59	17.21	6.61	12.62	20.09	10.77	10.68
ROCE (%)	N/A	12.15	15.98	19.49	12.02	14.64	18.68	15.25	13.65
Asset Turnover Ratio	4.58	3.93	3.46	3.43	2.73	2.46	3.02	2.49	1.8
PAT to CFO Conversion(x)	N/A	N/A	0	-0.5	1	1	-0.8	-4.14	0.73
Working Capital Days
Receivable Days	63	67	64	57	65	82	68	61	80
Inventory Days	10	15	21	22	34	39	36	48	62
Payable Days	60	58	49	39	41	61	64	70	64

Sudarshan Pharma Industries Ltd Stock News

Sudarshan Pharma Industries Ltd FAQs

What is the share price of Sudarshan Pharma Ind?

Company share prices are keep on changing according to the market conditions. The closing price of Sudarshan Pharma Ind on 17-Jun-2025 16:59 is ₹28.82.

What is the market cap of Sudarshan Pharma Ind?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Jun-2025 16:59 the market cap of Sudarshan Pharma Ind stood at ₹707.5.

What is the P/E ratio of Sudarshan Pharma Ind?

The latest P/E ratio of Sudarshan Pharma Ind as of 17-Jun-2025 16:59 is 44.56.

What is the P/B ratio of Sudarshan Pharma Ind?

The latest P/B ratio of Sudarshan Pharma Ind as of 17-Jun-2025 16:59 is 5.55.

What is the 52-week high and low of Sudarshan Pharma Ind?

The 52-week high of Sudarshan Pharma Ind is ₹53.50 and the 52-week low is ₹7.35.

What is the TTM revenue of Sudarshan Pharma Ind?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sudarshan Pharma Ind is ₹502.5 ( Cr.) .

About Sudarshan Pharma Industries Ltd

Sudarshan Pharma Industries was originally incorporated on July 23, 2008 as a Private Limited Company as “Sudarshan Speciality Chemsolve Private Limited” under the provisions of the Companies Act, 1956 with the Registrar of Companies, Mumbai. Later in the year 2016, the name of the company was changed from “Sudarshan Specialty Chemsolve Private Limited” to “Sudarshan Pharma Industries Private Limited” under the Companies Act, 2013 pursuant to a special resolution passed by its shareholders at the EGM held on November 25, 2016 and vide certificate of incorporation dated December 17, 2016 issued by the Registrar of Companies, Mumbai. Subsequently, pursuant to a Special Resolution of its Shareholders passed in the Extra-Ordinary General Meeting held on December 12, 2016 the company was converted from a Private Limited Company to Public Limited Company and consequently, the name of the company was changed to ‘Sudarshan Pharma Industries Limited’ and a Fresh Certificate of Incorporation consequent to Conversion was issued on January 05, 2017 by the Registrar of Companies, Mumbai.

The company is engaged in the business of manufacturing and trading of specialty chemicals & intermediates for pharma, agro chemicals, coating, paints, adhesive and various other industries. It is also into Active Pharmaceuticals Ingredients manufacturing. Some products it outsources and manufactures at its toll manufacturing facility, it is also into specialty chemicals imports & exports as well as supply of same to the actual users. As per the clients need and requirements, it provides customize specialty chemicals to its clients in India and abroad regularly. Its Specialty chemicals & its Intermediates have wide application in sectors like pharma, agro chemicals, performance chemicals, resins, paint, food, adhesive and various other Industries.

It is also involved in contract manufacturing, outsource & supply of generic pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It carries about Ethical marketing of pharmaceutical formulation & products in the Domestic and International market through its own distribution network and Sales force under its own brands. The company & its executives have developed the skill and expertise in innovation in specialty chemical, bulk drugs, API and pharmaceutical formulation to provide the products having wide application in pharma, agro chemicals, performance chemicals, resins, paint, food, adhesive and various other Industries. It offers services of QC and Formulation Development to provide customised solutions to its customers and assists them in sourcing the innovative products as per their needs.

Business area of the company

The company is engaged in the business of manufacturing and trading of Specialty Chemicals, Intermediates & Active Pharmaceuticals Ingredients.

Products and services of the company

Pharmaceuticals, finished formulations, key starting materials for API
Bulk drugs and intermediates
Paints, coatings, corrosive, inhibitors & inks
Food, fragrance & perfumes
Pesticides and agro chemicals
Fiber, PVC and adhesives
Cosmetic and detergents

History and milestones

2008: Incorporation of the company in the name and style of “Sudarshan Specialty Chemsolve Private Limited”
2011: Generic formulations for institution supply, NGO’s and wholesale market
2012: Branded Generic formulations in Maharashtra
2013: Established its footprints in Gujarat, West Bengal, Chhattisgarh and Uttar Pradesh
2014: Introduced brands in New Drug Delivery System
2015: Over 5,000 medical practitioners associated with SPIL
2016: Company’s name was changed from “Sudarshan Specialty Chemsolve Private Limited” to “Sudarshan Pharma Industries Private Limited”
2016: 7 own branded products introduced successfully in Vimac
2017: Conversion of the company from Private Limited Company to Public Limited Company and Change of name of Company to Sudarshan Pharma Industries Limited
2018: Brand Brilliance Award from Asian African leadership forum in Pharma
2019: Launch Hart Kit Loading Dose and Hart Kit-4
2021: VD-Section Got 50.00 crore Government order (Started work on CORONA protection)

SEBI Registered: Investment Adviser - INA000013323 RIA Details

Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.

Compliance Officer:

Name: Shrikant Jagtap

Email: shrikant.jagtap@moneyworks4me.com

Mobile No: +91 97638 00745

Grievance Officer:

Name: Mukta Vaze

Email: mukta.vaze@moneyworks4me.com

Mobile No:+91 98609 19463

Principal Officer:

Name: Atharva Bhide

Email: atharva.bhide@moneyworks4me.com

Mobile No:+91 91758 99463

SEBI regional/local office address-

Plot No. C 4-A , G Block, Near Bank of India, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra 400051

Address:

The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Data provided by Accord Fintech Pvt. Ltd.

Please wait your portfolio is updating...

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity - May 16, 2019 - Perpetual
BASL Membership ID:	BASL1187
Address	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Sudarshan Pharma Industries Ltd - Stock Valuation and Financial Performance

Sudarshan Pharma Ind Share Price

DeciZen - make an informed investing decision on Sudarshan Pharma Ind Share

Overall Rating ⓘ

1. Quality

2. Valuation ⓘ

3. Price Trend

Sudarshan Pharma Industries stock performance -

Is Sudarshan Pharma Industries Ltd an attractive stock to invest in?

1. Is Sudarshan Pharma Industries Ltd a good quality company?

2. Is Sudarshan Pharma Industries Ltd undervalued or overvalued?

3. Is Sudarshan Pharma Industries Ltd a good buy now?

10 Year X-Ray of Sudarshan Pharma Ind: Share

Analysis of Financial Track Record

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Recent Performance Summary

Latest Financials - Sudarshan Pharma Industries Ltd.

Management X-Ray of Sudarshan Pharma Ind: Share

Shareholding Pattern

Promoter's Holding & Share Pledging